Deerfield Capital Management
North America, Illinois, United States, Rosamond
Description
Deerfield Capital Management (DCM) is a global fixed-income investment adviser
Investor Profile
Deerfield Capital Management has backed more than 43 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 21% of its total and boasts 30 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States, Israel, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical.
Stage Focus
- Series C (19%)
- Series B (16%)
- Series D (14%)
- Post Ipo Equity (12%)
- Series E (7%)
- Series Unknown (7%)
- Series A (7%)
- Debt Financing (5%)
- Series F (5%)
- Private Equity (5%)
Country Focus
- United States (86%)
- Israel (7%)
- United Kingdom (5%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Medical Device
- Genetics
- Hospital
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
